Area of research
Infectious Diseases · Hepatology
Research interest
Research interests include Hepatitis C virus research, HIV/AIDS Research and Interventions, HIV-related health complications and treatments, and HIV/AIDS drug development and treatment.
The urgent need for implementation science to achieve hepatitis C elimination
Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virus
National hepatitis B and C estimates for 2021: Measuring Canada’s progress towards eliminating viral hepatitis as a public health concern
Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration
Joint statement in support of hepatitis C human challenge studies
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study
Snowmass 2021 Whitepaper: Proton Structure at the Precision Frontier
Intersecting HIV and mpox epidemics: more questions than answers
Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infection
The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007–2017
Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV
Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015
Risk of HCC With Hepatitis B Viremia Among HIV/HBV‐Coinfected Persons in North America
Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor–Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada
Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005–2015
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies
Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study
Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission
Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras
Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada
Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C Virus–Monoinfected Patients
End-Stage Renal Disease Among HIV-Infected Adults in North America
Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C Virus–Infected, and Uninfected Patients
Disparities in the Quality of HIV Care When Using US Department of Health and Human Services Indicators
Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada